Tuesday, December 08, 2015 4:22:11 PM
After reading the PR's from today a couple of things are very apparent. NW wanted an internal investigation into all of the Phase 5 allegations and wanted Leary to head that effort. Linda has not only rejected his recommendation, but she has also deflected the internal investigation and will instead hire folks to look outward with a focus on stock manipulation. It is exactly what I expected. I have zero confidence in this management team and I believe Neil Woodford shares this opinion.
Here are a few things that a few of the most vocal bulls around here have postulated recently:
The Phase V report is completely bogus and should not be addressed or acknowledged by NWBO. In reality - NW calls for an investigation into the allegations.
NW, Linda, and Ondra are working together to increase value and strategize a way forward. In reality - NW and LP engage in a public pissing match. LP snubs Woodfords request and is unwilling to conduct an internal investigation. She will instead focus on short sellers.
L trial has completed enrollment, it's a done deal. In reality - PR from today clearly states the Direct Phase 1 trial has completed enrollment and that the L trial is currently under a PARTIAL CLINICAL HOLD.
Some folks are either internationally posting incorrect theories/speculation, or are just consistently miles away from the truth or reality of the situation.
Here are a few things that a few of the most vocal bulls around here have postulated recently:
The Phase V report is completely bogus and should not be addressed or acknowledged by NWBO. In reality - NW calls for an investigation into the allegations.
NW, Linda, and Ondra are working together to increase value and strategize a way forward. In reality - NW and LP engage in a public pissing match. LP snubs Woodfords request and is unwilling to conduct an internal investigation. She will instead focus on short sellers.
L trial has completed enrollment, it's a done deal. In reality - PR from today clearly states the Direct Phase 1 trial has completed enrollment and that the L trial is currently under a PARTIAL CLINICAL HOLD.
Some folks are either internationally posting incorrect theories/speculation, or are just consistently miles away from the truth or reality of the situation.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
